← Back to patent-cliff list
Luminol sodium
Tier C — Watch / tradeLuminol sodium
Selvim
Originator
1997
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：IL6, TNFα
Indications (approved)：免疫紊乱, Psoriasis
Regional status
US
Phase II
2021-10-19
EU
Phase II
2016-05-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Luminol sodium?
Approved indications include: 免疫紊乱, Psoriasis.
When does the Luminol sodium patent expire?
No public expiry year is available for Luminol sodium yet; this page updates once verified.
How do I get a quote for Luminol sodium intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27